Fulcrum Therapeutics Insider Trades
NASDAQ: FULCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 6 · $1.49M
- Sales
- 9 · $59.15M
- Shares bought / sold
- 417.56K / 4.26M
- Net activity
- Net selling $57.7 million
Fulcrum Therapeutics insider activity
Over the last 12 months, Fulcrum Therapeutics insiders reported 15 transactions on SEC Form 4: 6 open-market purchases and 9 sales. Insiders bought $1.5 million and sold $59.2 million worth of stock, for net insider selling of $57.7 million. The largest seller was RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M., with $58.4 million in reported sales.
The most recent filing shows TANG KEVIN & TANG CAPITAL MANAGEMENT LLC (10% Owner) buying 50,945 shares at $3.52 on Jul 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put FULC's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
FULC insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 17, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLC10% Owner | Buy | 50,945 | $179.33K | Form 4 |
| Jul 16, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLC10% Owner | Buy | 116,671 | $415.35K | Form 4 |
| Jul 15, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLC10% Owner | Buy | 107,377 | $382.26K | Form 4 |
| Jul 14, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLC10% Owner | Buy | 75,952 | $271.91K | Form 4 |
| Jul 14, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLC10% Owner | Buy | 53,651 | $191.00K | Form 4 |
| Jul 13, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLC10% Owner | Buy | 12,966 | $45.90K | Form 4 |
| Jun 26, 2026 | Ezekowitz AlanDirector | Sale | 18,000 | $65.61K | Form 4 |
| Feb 2, 2026 | Gould Robert JDirector | Sale | 15,000 | $160.86K | Form 4 |
| Jan 2, 2026 | Gould Robert JDirector | Sale | 15,000 | $178.09K | Form 4 |
| Jan 2, 2026 | Gould Robert JDirector | Sale | 15,000 | $163.09K | Form 4 |
| Dec 15, 2025 | Oltmans Curtis GaleChief Legal Officer | Sale | 3,452 | $44.60K | Form 4 |
| Dec 8, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | Sale | 91,722 | $1.37M | Form 4 |
| Dec 8, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | Sale | 2,706,397 | $38.65M | Form 4 |
| Dec 8, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | Sale | 1,377,020 | $18.36M | Form 4 |
| Nov 19, 2025 | Gould Robert JDirector | Sale | 15,000 | $165.50K | Form 4 |
| May 8, 2025 | Tourangeau GregPrincipal Accounting Officer | Sale | 498 | $2.52K | Form 4 |
| Aug 21, 2024 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | other | 8,500,000 | — | Form 4 |
| Jul 3, 2024 | Sapir AlexSee Remarks | Option exercise | 150,000 | $490.50K | Form 4 |
| Jul 22, 2019 | Sanofi10% Owner | Buy | 93,750 | $1.50M | Form 4 |
| Jul 22, 2019 | Sanofi10% Owner | Conversion | 464,285 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4